US98956P1021
US98956P1021
Zimmer Biomet Holdings, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 17B EUR | 16.41B EUR | 17.49B EUR | 17.58B EUR |
Enterprise Value | 24.1B EUR | 23.47B EUR | 24.53B EUR | 24.5B EUR |
Valuation Multiples | ||||
Trailing P/E | 21.64x | 20.34x | 22.98x | 33.61x |
Forward P/E | 9.83x | -- | -- | -- |
Price to Sales | 2x | 1.93x | 2.08x | 2.78x |
Price to Book | 1.35x | 1.3x | 1.38x | 1.38x |
EV/Revenue | 2.83x | 2.76x | 2.92x | 3.88x |
EV/EBITDA | 9.54x | 9.33x | 9.65x | 13.04x |
Price to FCF (P/FCF) | 15.86x | 11.7x | 12.78x | 16.21x |
EV/FCF | 22.48x | 16.75x | 17.93x | 22.6x |
FCF Yield | 6.31% | 8.54% | 7.83% | 6.17% |